About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
WASHINGTON, D.C. (June 27, 2025) – Today, Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Director of Public Affairs Andrew Powaleny issued the following statement:
“It’s vital that decisions impacting vaccine recommendations and patient access are grounded in science. While it’s positive to see the RSV recommendation, we remain concerned that the committee is basing recommendations related to the use of thimerosal in flu vaccines and future plans to revisit the childhood immunization schedule on theories that ignore decades of scientific evidence. We remain troubled that this type of approach could further fuel vaccine skepticism and risk patients’ access to life saving vaccines.”